| Pubmed ID |
Author | Year | Title |
23948280 |
Hacivelioglu S | 2013 | Acne severity and the Global Acne Grading System in polycystic ovary syndrome. |
23948452 |
Wiser A | 2013 | Age-related normogram for antral follicle count in women with polycystic ovary syndrome. |
23951943 |
Minagawa K | 2013 | [Characteristics of women with epilepsy who developed polycystic ovary syndrome owing to the therapy with valproate sodium]. |
23953589 |
Li Y | 2013 | Association of AQP8 in women with PCOS. |
23956870 |
Capula C | 2013 | Predictors of postpartum glucose tolerance testing in italian women with gestational diabetes mellitus. |
23957781 |
Shabir I | 2013 | Morning plasma cortisol is low among obese women with polycystic ovary syndrome. |
23957782 |
Morgante G | 2013 | Alterations in thyroid function among the different polycystic ovary syndrome phenotypes. |
23958241 |
Ciaraldi TP | 2013 | Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment. |
23960423 |
Saha L | 2013 | N-acetyl cysteine in clomiphene citrate resistant polycystic ovary syndrome: A review of reported outcomes. |
23960719 |
Khalaf BH | 2010 | Leptin levels in relation to marital status and neuroendocrine function in Iraqi females with polycystic ovary syndrome. |
23961469 |
Bajaj S | 2013 | South Asian women with diabetes: Psychosocial challenges and management: Consensus statement. |
23961484 |
Ahmadi A | 2013 | Anthropometric characteristics and dietary pattern of women with polycystic ovary syndrome. |
23961784 |
Enli Y | 2013 | Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome. |
23969185 |
Georgopoulos NA | 2013 | Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels. |
23971241 |
Check JH | 2013 | Dihydrotestosterone may contribute to the development of migraine headaches. |
23971253 |
Vaggopoulos V | 2013 | The prevalence of phenotypic subgroups in Greek women with polycystic ovarian syndrome. |
23975191 |
Deepika ML | 2013 | TNF-? haplotype association with polycystic ovary syndrome - a South Indian study. |
23977829 |
Schrager S | 2013 | Cardiovascular disease in women: contraceptive issues and nonvalvular cardiovascular disease. |
23978544 |
August P | 2013 | Hypertension in women. |
23979790 |
Li S | 2013 | The expression of 11?-HSDs, GR, and H6PDH in subcutaneous adipose tissue from polycystic ovary syndrome subjects. |
23979947 |
Mahran A | 2013 | The predictive value of circulating anti-M?llerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study. |
23980058 |
Zhang X | 2013 | Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats. |
23980352 |
Chen Y | 2013 | [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease]. |
23980726 |
Sahmay S | 2013 | Elevated serum levels of anti-M?llerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome. |
23981122 |
Yilmaz ? | 2013 | The relationship of urotensin II with insulin resistance and hs-CRP in patients having PCOS. |
23981769 |
Morotti E | 2013 | Body imaging and sexual behavior in lean women with polycystic ovary syndrome. |
23988170 |
Velija-A?imi Z | 2013 | Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment. |
23994294 |
Shen W | 2013 | Calpain-10 genetic polymorphisms and polycystic ovary syndrome risk: a meta-analysis and meta-regression. |
23994667 |
Rochester JR | 2013 | Bisphenol A and human health: a review of the literature. |
23996806 |
Erdo?an E | 2013 | Subclinical left ventricular dysfunction in women with polycystic ovary syndrome: an observational study. |
23998514 |
Ates S | 2013 | Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics. |
23999280 |
Barr S | 2013 | An isocaloric low glycemic index diet improves insulin sensitivity in women with polycystic ovary syndrome. |
24001418 |
Pavi?i? Baldani D | 2013 | Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome. |
24001751 |
Arusoglu G | 2013 | Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive. |
24002401 |
Livadas S | 2013 | Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach. |
24002402 |
Catteau-Jonard S | 2013 | Pathophysiology of polycystic ovary syndrome: the role of hyperandrogenism. |
24002403 |
Barber TM | 2013 | Genetics of polycystic ovary syndrome. |
24002404 |
Carmina E | 2013 | Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome. |
24002405 |
Macut D | 2013 | Dyslipidemia and oxidative stress in PCOS. |
24002406 |
Bajuk Studen K | 2013 | Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome. |
24002407 |
Pasquali R | 2013 | Insulin sensitizers in polycystic ovary syndrome. |
24002408 |
Unluhizarci K | 2013 | Hirsutism - from diagnosis to use of antiandrogens. |
24002409 |
Bozdag G | 2013 | Combined oral contraceptives in polycystic ovary syndrome - indications and cautions. |
24002410 |
Panidis D | 2013 | Infertility treatment in polycystic ovary syndrome: lifestyle interventions, medications and surgery. |
24002411 |
Alexandraki KI | 2013 | Endocrinopathies and other disorders inducing a polycystic ovary syndrome phenotype. |
24002412 |
Pignatelli D | 2013 | Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome. |
24005592 |
Joe-kechebelu NN | 2013 | Familial trend in polycystic ovarian syndrome: report of two cases. |
24009134 |
Dunaif A | 2013 | Renaming PCOS--a two-state solution. |
24013985 |
Schwetz V | 2014 | Osteocalcin levels on oral glucose load in women being investigated for polycystic ovary syndrome. |
24014214 |
Ghanem ME | 2013 | Clomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial. |
24014601 |
Anand-Ivell R | 2013 | Circulating insulin-like factor 3 (INSL3) in healthy and infertile women. |
24014605 |
Comim FV | 2013 | Increased protein expression of LHCG receptor and 17?-hydroxylase/17-20-lyase in human polycystic ovaries. |
24014819 |
Rothman M | 2013 | PCOS: what teens need to know. |
24020909 |
Di Carlo C | 2013 | Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary study. |
24020937 |
Guleria AK | 2014 | Cardiovascular disease risk in young Indian women with polycystic ovary syndrome. |
24023577 |
Kuang H | 2013 | Acupuncture and clomiphene citrate for live birth in polycystic ovary syndrome: study design of a randomized controlled trial. |
24023708 |
Bungum L | 2013 | The circadian variation in Anti-M?llerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women. |
24024320 |
Yu L | 2013 | Effects of electroacupuncture and Chinese kidney-nourishing medicine on polycystic ovary syndrome in obese patients. |
24026057 |
Lebbe M | 2013 | Involvement of androgens in ovarian health and disease. |
24030183 |
Medeiros SF | 2013 | New insights into steroidogenesis in normo- and hyperandrogenic polycystic ovary syndrome patients. |
24031110 |
Samsami Dehaghani A | 2013 | Anti-Nuclear Antibodies in Patients with Polycystic Ovary Syndrome before and after Laparoscopic Electrocauterization. |
24032264 |
Brzozowska M | 2013 | [The role of vitamin D deficiency in the etiology of polycystic ovary syndrome disorders]. |
24032272 |
Milewski R | 2013 | [Analysis of the demographic profile of patients treated for infertility using assisted reproductive techniques in 2005-2010]. |
24034940 |
Michaliszyn SF | 2013 | Polycystic ovary syndrome and nonalcoholic fatty liver in obese adolescents: association with metabolic risk profile. |
24036000 |
Jimenez PT | 2013 | DHEA-mediated inhibition of the pentose phosphate pathway alters oocyte lipid metabolism in mice. |
24037889 |
Murri M | 2013 | Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression. |
24040195 |
Chakraborty P | 2013 | Aspirin and low-molecular weight heparin combination therapy effectively prevents recurrent miscarriage in hyperhomocysteinemic women. |
24040456 |
Yang J | 2013 | The association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene with the metabolic characteristics in Chinese women with polycystic ovary syndrome. |
24044903 |
Krul-Poel YH | 2013 | The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review. |
24045781 |
Kawada T | 2013 | Sleep efficiency in patients with polycystic ovarian syndrome. |
24045782 |
Shreeve N | 2013 | Reply: sleep efficiency in patients with polycystic ovarian syndrome. |
24051942 |
Cappelli V | 2013 | [Evaluation of a new association between insulin-sensitizers and ?-lipoic acid in obese women affected by PCOS]. |
24052006 |
Yum KS | 2013 | Pattern of voiding dysfunction after acute brainstem infarction. |
24056171 |
Thompson IR | 2014 | GnRH pulse frequency-dependent differential regulation of LH and FSH gene expression. |
24057296 |
Lauria PB | 2013 | Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome. |
24064685 |
Welt CK | 2013 | Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. |
24068296 |
Strowitzki T | 2013 | In vitro maturation (IVM) of human oocytes. |
24069859 |
Nawrocka-Rutkowska J | 2013 | Insulin resistance assessment in patients with polycystic ovary syndrome using different diagnostic criteria--impact of metformin treatment. |
24073009 |
Johansson J | 2013 | Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction. |
24077439 |
Veiga-Lopez A | 2014 | Developmental programming: postnatal estradiol amplifies ovarian follicular defects induced by fetal exposure to excess testosterone and dihydrotestosterone in sheep. |
24078159 |
El-Shal AS | 2013 | Genetic variation in the vitamin D receptor gene and vitamin D serum levels in Egyptian women with polycystic ovary syndrome. |
24079935 |
Hara S | 2013 | Pioglitazone counteracts the tumor necrosis factor-? inhibition of follicle-stimulating hormone-induced follicular development and estradiol production in an in vitro mouse preantral follicle culture system. |
24081730 |
Joham AE | 2014 | Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome. |
24082083 |
Kawamura K | 2013 | Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. |
24082649 |
Kar S | 2013 | Current evidence supporting letrozole for ovulation induction. |
24084835 |
Nohara K | 2013 | Developmental androgen excess disrupts reproduction and energy homeostasis in adult male mice. |
24086769 |
Eriksen MB | 2013 | Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS). |
24087928 |
Insenser M | 2013 | Proteomics and polycystic ovary syndrome. |
24091229 |
Bostedt H | 2013 | [Clinical and endocrinological findings of bitches with ovarian cyst syndrome]. |
24092830 |
Domecq JP | 2013 | Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis. |
24092831 |
Brower M | 2013 | The severity of menstrual dysfunction as a predictor of insulin resistance in PCOS. |
24092832 |
Domecq JP | 2013 | Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. |
24095114 |
Engeland WC | 2013 | Sensitization of endocrine organs to anterior pituitary hormones by the autonomic nervous system. |
24096951 |
Horn M | 2013 | Polycystic ovary syndrome in adolescents: (women's health series). |
24098506 |
Meng Y | 2013 | Downregulated expression of peroxiredoxin 4 in granulosa cells from polycystic ovary syndrome. |
24099797 |
Khalil RA | 2013 | Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease. |
24101226 |
Huddleston HG | 2013 | Biomarkers of ovarian reserve in women with polycystic ovary syndrome. |
24101529 |
Siristatidis CS | 2013 | In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction. |
24102267 |
Kulshreshtha B | 2013 | Family background of Diabetes Mellitus, obesity and hypertension affects the phenotype and first symptom of patients with PCOS. |
24102794 |
Saranya K | 2014 | Assessment of cardiovascular autonomic function in patients with polycystic ovary syndrome. |
Showing 11,201–11,300 of 14,368